{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:58:09Z","timestamp":1760853489360,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006730","name":"Ministry of Education and Research, Romania","doi-asserted-by":"publisher","award":["PN-II-ID-PCE-2008"],"award-info":[{"award-number":["PN-II-ID-PCE-2008"]}],"id":[{"id":"10.13039\/501100006730","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.mehy.2010.07.051","type":"journal-article","created":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T05:35:25Z","timestamp":1283319325000},"page":"627-629","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Considerations concerning design and mechanism of action of a new class of anticancer dual DNA intercalators"],"prefix":"10.1016","volume":"75","author":[{"given":"Mihaela C\u0103t\u0103lina C.","family":"Luca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasile V.","family":"Tura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ionel I.","family":"Mangalagiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2007","series-title":"Global cancer facts and figures 2007","author":"Garcia","key":"10.1016\/j.mehy.2010.07.051_b0005"},{"year":"2005","series-title":"Goodman and Gilman\u2019s the pharmacological basis of therapeutics","author":"Brunton","key":"10.1016\/j.mehy.2010.07.051_b0010"},{"key":"10.1016\/j.mehy.2010.07.051_b0015","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrd1984","article-title":"Targeting multidrug resistance in cancer","volume":"5","author":"Szak\u00e1cs","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.mehy.2010.07.051_b0020","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.mehy.2009.05.017","article-title":"Primary tumor resection may improve prognosis for nonoperable advanced breast cancer","volume":"73","author":"Zhang","year":"2009","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2010.07.051_b0025","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1016\/j.ejmech.2008.07.016","article-title":"Synthesis and in vitro cytotoxicity of 9-anilinoacridines bearing N-mustard residue on both anilino and acridine rings","volume":"44","author":"Chen","year":"2009","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.mehy.2010.07.051_b0030","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.ejmech.2006.12.039","article-title":"Design, synthesis and biological evaluation of new oligopyrrole carboxamides linked with tricyclic DNA-intercalators as potential DNA ligands or topoisomerase inhibitors","volume":"42","author":"David-Cordonnier","year":"2007","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.mehy.2010.07.051_b0035","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1016\/S0968-0896(02)00097-4","article-title":"Synthesis and analysis of urea and carbamate prodrugs as candidates for MDEPT","volume":"10","author":"Jordan","year":"2002","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.mehy.2010.07.051_b0040","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00280-007-0435-6","article-title":"O4-benzylfolic acid inactivates O6-alkylguanine-DNA alkyltransferase in brain tumor cell lines","volume":"60","author":"Johnson","year":"2007","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.mehy.2010.07.051_b0045","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/CAD.0b013e32832cad9b","article-title":"Nitroimidazole-based bioreductive compounds bearing a quinazoline or a naphthyridine chromophore","volume":"20","author":"Papadopoulou","year":"2009","journal-title":"Anti-Cancer Drug"},{"key":"10.1016\/j.mehy.2010.07.051_b0050","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.mehy.2008.05.002","article-title":"Multi-anticancer drugs encapsulated in the micelle: a novel chemotherapy to cancer","volume":"71","author":"Liu","year":"2008","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2010.07.051_b0055","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.3987\/COM-05-10428","article-title":"Synthesis and antimicrobial activity of some new pyridazine derivatives","volume":"65","author":"Caprosu","year":"2005","journal-title":"Heterocycles"},{"key":"10.1016\/j.mehy.2010.07.051_b0060","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/j.ejmech.2008.06.017","article-title":"Diazinium salts with dihydroxyacetophenone skeleton: syntheses and antimicrobial activity","volume":"44","author":"Balan","year":"2009","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.mehy.2010.07.051_b0065","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1016\/j.bmc.2009.02.028","article-title":"New pyridazine derivatives: synthesis, chemistry and biological activity","volume":"15","author":"Butnariu","year":"2009","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.mehy.2010.07.051_b0070","first-page":"1","article-title":"Design, synthesis and in vitro anticancer activity of a new class of bifunctional DNA intercalators","volume":"7","author":"Zbancioc","year":"2010","journal-title":"Lett Drug Des Discov"},{"key":"10.1016\/j.mehy.2010.07.051_b0090","unstructured":"(a) US National Cancer Institute (NCI). Bethesda, http:\/\/dtp.nci.nih.gov\/; (b) Doyle A, Griffits JB. Cell and tissue culture: laboratory procedures in biotechnologies. West Sussex: Wiley; 1998."}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987710002987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987710002987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:12:58Z","timestamp":1759691578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987710002987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0306987710002987"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2010.07.051","relation":{},"ISSN":["0306-9877"],"issn-type":[{"type":"print","value":"0306-9877"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Considerations concerning design and mechanism of action of a new class of anticancer dual DNA intercalators","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2010.07.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}